Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A. Anderson, Punit P. Seth, William J. Drury et al.|Nucleic Acids Research|2021Cited by 129
Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotidesMichael E. Østergaard, Punit P. Seth, Cheryl Li De Hoyos et al.|Nucleic Acids Research|2020Cited by 98